Literature DB >> 8151378

Clinical utility of technetium-99m-teboroxime myocardial washout imaging.

M J Henzlova1, J Machac.   

Abstract

UNLABELLED: The purpose of this study was to evaluate the clinical utility of 99mTc-teboroxime myocardial washout imaging. The differential washout after a single tracer injection has been proposed as an alternative for characterization of the perfusion defects.
METHODS: Fifty-six patients received 5-min adenosine infusion. The stress dose of 99mTc-teboroxime was injected at 4.5 min and stress imaging with a single-headed SPECT gamma camera was started at 6 min, washout imaging followed immediately. At 20 min, the rest tracer dose was injected at rest and imaging was started at 21.5 min. The reversibility of the perfusion defects on the washout and rest images was compared visually and quantitatively.
RESULTS: There was no statistical difference in the number of stress defects that improved on the washout and rest images. The visual interpretation of the perfusion abnormalities was confirmed by quantitative analysis of relative segmental activity.
CONCLUSION: Thus, 99mTc-teboroxime-adenosine washout myocardial perfusion imaging can be safely and quickly accomplished. Detected reversibility of the perfusion defects did not significantly differ from reversibility observed on the rest images.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151378

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  3 in total

1.  Detectability of perfusion defect in five-dimensional gated-dynamic cardiac SPECT images.

Authors:  Xiaofeng Niu; Yongyi Yang; Michael A King; Miles N Wernick
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  Simultaneous assessment of cardiac perfusion and function using 5-dimensional imaging with Tc-99m teboroxime.

Authors:  Bing Feng; P Hendrik Pretorius; Troy H Farncombe; Seth T Dahlberg; Manoj V Narayanan; Miles N Wernick; Anna M Celler; Jeffrey A Leppo; Michael A King
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

3.  Technetium 99m-labeled teboroxime: death in utero, infanticide, or failure to thrive?

Authors:  R J Burns
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.